Ergoteles’s Dogwood Therapeutics DWTX Stock Holding History

Ergoteles’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,292	Closed	-$7.63K	–	1831
2022 Q4	$7.63K	Buy	+1,292	New	+$9.73K	﹤0.01%	1376

Other funds holding DWTX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Ergoteles's DWTX Position: Q1 2023 in Review

Ergoteles sold out of Dogwood Therapeutics (DWTX) in Q1 2023, closing a stake of 1,292 shares — an estimated $7.63K sold.

Ergoteles first reported a position in DWTX in Q4 2022 and held it in 1 quarter. The position peaked at $7.63K in Q4 2022. 23 funds tracked by Wall St. Rank hold DWTX as of Q1 2023.

Ergoteles reported no remaining Dogwood Therapeutics position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 1,292 Dogwood Therapeutics shares in Q1 2023, an estimated $7.63K.
Ergoteles first reported a position in Dogwood Therapeutics in Q4 2022 and held it in 1 quarter.
Ergoteles's Dogwood Therapeutics position peaked at $7.63K in Q4 2022.
23 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.